European Medicines Agency (EMA) and European medicines regulatory network lift COVID-19 business continuity status

5 maggio 2023 – EMA and the European medicines regulatory network are lifting their respective COVID-19 business continuity measures after successfully handling the unprecedented operational challenges posed by the pandemic. This was foreseen in PDF icon EMA’s workplan for 2023-2025.

For more information, see here.